Visalia
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
14- Dermatology
- 9
- Plastic Surgery
- 5
How aesthetic practices vet a biologics vendor
Dermatology practices, plastic surgery practices, and medspas typically review a prospective biologics supplier the same way they review any clinical-grade vendor: checking that registration and licensure documentation is available on request, requesting a certificate of analysis and donor eligibility summary for a specific lot, and confirming ordering access runs through NPI verification rather than an open storefront. Because exosome products carry no FDA approval and are generally treated as biologic drugs, many practices route that review through their medical director before committing to a vendor.
Physician supervision and medical director sign-off
A medspa operating under physician supervision generally needs its medical director to sign off on a new biologics vendor, separate from NPI account verification at Precision Biologics, which confirms the account but not the practice's internal supervision requirements. Confirming the supervising physician's standing with the Medical Board of California and reviewing the purchase with counsel is a step the practice handles on its own.
Handling shipments
Cryopreserved Wharton's jelly vials arrive overnight on dry ice and move directly into -80 degree C storage; lyophilized exosome products are shelf-stable and are stored per the insert supplied with the lot, so no cold-chain step is needed for those formats. Either way, the lot identifier should be logged against the patient record on receipt.
Opening an account
Account setup starts with NPI verification, typically under the medical director's number. Once verified, a practice can request full ingredient disclosure for lyophilized exosome products and lot-specific characterization data, and can schedule a physician-level call focused on that documentation.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Do we need a medical director's NPI to open an account?+
Yes, typically. Medspas operating under physician supervision generally verify their Precision Biologics account under the supervising physician's or medical director's NPI number.
What does the 14-provider count on this page represent?+
It is the number of individually registered NPI-1 providers with a Visalia practice location and a Dermatology or Plastic Surgery taxonomy in the NPPES registry as of 2026-10-27, not a measure of medspa demand.
Are exosome products FDA approved for aesthetic use?+
No. FDA has stated there are no FDA-approved exosome products. They are generally regulated as biologic drugs, and any purchase or use decision rests with the practice's physician and its own regulatory counsel.